{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:56Z","timestamp":1761058736492,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p>OBJECTIVE: Calcium antagonists are the only oral vasodilators shown to influence mortality in primary pulmonary hypertension, but the high doses required are often poorly tolerated. Amlodipine is a novel, relatively well tolerated, calcium antagonist. It has not been previously tested in humans with pulmonary hypertension. DESIGN: Calcium antagonists are claimed to be of benefit in the 20-30% of patients who respond--that is, whose mean pulmonary artery pressure and pulmonary vascular resistance decreased by 20% after acute administration. Increasing oral doses of amlodipine (up to 40 mg) were given and haemodynamic measurements were obtained by the use of indwelling pulmonary artery catheters 12 h after each dose. SETTING: Large teaching hospital, primary referral centre. PATIENTS: Six patients (four women; age range 37-78 years) with pulmonary hypertension (one with primary pulmonary hypertension, five with thromboembolic disease. MAIN OUTCOME MEASURES: Mean pulmonary artery pressure and pulmonary vascular resistance decreased by greater than 20% in two patients, mean pulmonary artery pressure decreased by greater than 20% in one patient with a pulmonary vascular resistance reduction of 19%. Thus, two of six patients responded to amlodipine and one partially responded. RESULTS: The whole group mean (SEM) pulmonary artery pressure decreased from 47.7 (4.2) to 41.7 (4.4) mm Hg and mean pulmonary vascular resistance from 8.6 (2.1) to 7.1 (1.8) Wood units. Cardiac output rose by a mean (range) of 4% (-20.8 to+20.8), heart rate by 8.8% (-10 to +33), and systemic systolic blood pressure decreased by 12% (-29.2 to -5.8) and diastolic blood pressure by 6.8% (-28.2 to+20.0). There were no symptoms of systemic hypotension. CONCLUSION: These results show that oral amlodipine can produce acute pulmonary vasodilatation in patients with pulmonary hypertension. Further studies are required, but amlodipine may prove to be of value in the treatment of primary pulmonary hypertension.<\/jats:p>","DOI":"10.1136\/hrt.75.2.171","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:46:00Z","timestamp":1190137560000},"page":"171-173","source":"Crossref","is-referenced-by-count":26,"title":["Acute pulmonary vasodilatory properties of amlodipine in humans with pulmonary hypertension."],"prefix":"10.1136","volume":"75","author":[{"given":"P. A.","family":"Woodmansey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Channer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Morice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1996,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9343(70)80115-2","article-title":"Primary pulmonary hypertension","volume":"49","author":"Wallcott, G.; Burchell, H.B.; AL, Jr, Brown","year":"1970","unstructured":"Wallcott G, Burchell HB, Brown AL Jr. Primary pulmonary hypertension. Am 7 Med 1970;49:70-9.","journal-title":"Am 7 Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00005792-198601000-00004","article-title":"Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature","volume":"65","author":"Hughes, J.D.; Rubin, U.","year":"1986","unstructured":"Hughes JD, Rubin U. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature. Medicine 1986;65:56-72.","journal-title":"Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich, S.; Dantzker, D.R.; Ayres, S.M.","year":"1987","unstructured":"Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.","journal-title":"Ann Intern Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich, S.; Kaufmann, E.; Levy, P.","year":"1992","unstructured":"Rich S, Kaufmann E, Levy P. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N EnglJ Med 1992;327:76-8 1.","journal-title":"N EnglJ Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.71.6.1191","article-title":"The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension","volume":"71","author":"Rich, S.; Brundage, B.H.; Levy, P.S.","year":"1985","unstructured":"Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985;71: 1191-6.","journal-title":"Circulation"},{"key":"ref_6","first-page":"478","article-title":"A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease","volume":"3","author":"Murdoch, D.; Amlodipine, Heel R.C.","year":"1991","unstructured":"Murdoch D, Heel RC. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991;3: 478-505.","journal-title":"Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0002-8703(89)90838-7","article-title":"The safety of amlodipine","volume":"118","author":"Osterloh, I.","year":"1989","unstructured":"Osterloh I. The safety of amlodipine. Am HeartJ 1989;118: 1114-20.","journal-title":"Am HeartJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of mild hypertension study","volume":"270","author":"Neaton, J.D.; Grimm, R.H.; Prineas, R.J.; Stamler, J.; Grandits, G.A.; Elmer, P.J.","year":"1993","unstructured":"Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study. JAMA 1993;270:713-24.","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/cs0850361","article-title":"The vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats","volume":"85","author":"Woodmansey, P.A.; Zhang, F.; Channer, K.S.; Morice, A.H.","year":"1993","unstructured":"Woodmansey PA, Zhang F, Channer KS, Morice AH. The vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats. Clin Sci 1993;85:361-6.","journal-title":"Clin Sci"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005344-199502000-00019","article-title":"The effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries","volume":"25","author":"Woodmansey, P.A.; Zhang, F.; Channer, K.S.; Morice, A.H.","year":"1995","unstructured":"Woodmansey PA, Zhang F, Channer KS, Morice AH. The effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. _J Cardiovasc Pharmacol 1995;25:324-9.","journal-title":"_J Cardiovasc Pharmacol"},{"key":"ref_11","first-page":"115","article-title":"Diagnosis and management of primary pulmonary hypertension","author":"Weir, E.K.","year":"1984","unstructured":"Weir EK. Diagnosis and management of primary pulmonary hypertension. In: Wier EK, Reeves JT, eds. Pulmonary hypertension. New York: Futura Publishing Company, 1984:115-68."},{"key":"ref_12","first-page":"127","article-title":"Treating pulmonary hypertension","volume-title":"The diagnosis and treatment of pulmonary hypertension","author":"Dantzker, DR","year":"1992","unstructured":"Dantzker DR. Treating pulmonary hypertension. In: Weir EK, Archer SL, Reeves JT, eds. The diagnosis and treatment of pulmonary hypertension. New York: Futura Publishing Company, 1992:127-38."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2125.1986.tb02874.x","article-title":"The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br3'","volume":"22","author":"Faulkner, J.K.; McGibney, D.; Chasseaud, L.F.; Perry, J.L.; Taylor, I.W.","year":"1986","unstructured":"Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br3' Clin Pharmacol 1986;22:21-5.","journal-title":"Clin Pharmacol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.71.4.761","article-title":"Haemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure","volume":"71","author":"Packer, M.; Medina, N.; Yushak, M.","year":"1985","unstructured":"Packer M, Medina N, Yushak M. Haemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation 1985;71:761-6.","journal-title":"Circulation"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.75.2.171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T07:54:26Z","timestamp":1758354866000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.75.2.171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1996,2,1]]},"published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1136\/hrt.75.2.171"],"URL":"https:\/\/doi.org\/10.1136\/hrt.75.2.171","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}